The Bloomberg/Schumer Report

Despite the recent downturn in securities class action filings, securities litigation reform is a hot topic. On the heels of the Committee on Capital Markets Regulation’s interim report, Mayor Bloomberg and Senator Schumer have issued “Sustaining New York’s and the US’ Global Financial Services Leadership.” The two reports cover much of the same ground, but there are differences in their securities litigation reform recommendations. After noting that “if economic conditions were to decline in the future, than a strong resurgence in [securities class actions] would likely follow,” the Bloomberg/Schumer report recommends (pp. 102-104):

(1) Limit the liability of foreign companies with U.S. listings to damages that are proportional to their degree of exposure to the U.S. markets. (SEC)

(2) Impose a cap on auditors’ liability. (SEC)

(3) Encourage arbitration as an alternative dispute resolution system for securities grievances. (SEC)

(4) Allow parties in federal securities actions to appeal interlocutory judgments (e.g., the denial of a motion to dismiss) immediately to the circuit courts. (Congress)

Coverage of the report can be found in the Financial Times (subscrip. req’d), Wall Street Journal (subscrip. req’d), and the New York Times. D&O Diary has a comprehensive summary.

Leave a comment

Filed under All The News That's Fit To Blog

The Coffee Reforms

In the Jan. 18 edition of the New York Law Journal, Professor John Coffee presents a wish list (subscrip. req’d) of securities litigation reforms. The proposed reforms are:

(1) Congress should impose a cap on auditor liability. To make this reform more politically acceptable, Congress could overturn Central Bank and restore private aiding and abetting liability for securities fraud (at least for accounting firms).

(2) Governor Spitzer should ban, by executive order, “pay to play” practices where lawyers “compete to be selected as class counsel for the public pension funds serving as ‘lead plaintiff’ in securities class actions by making political contributions to state and municipal comptrollers, who in some jurisdictions, including New York, have exclusive control over the pension fund.”

(3) Unlike almost every other state, there is no private right of action for securities fraud under New York law. Attorney General Cuomo should draft new legislation correcting this deficiency.

Quote of note: “Such a ceiling would not protect an audit firm from repetitive litigation resulting in repetitive large settlements – say, ten suits, each for $40 million on average. But a firm forced to settle those many actions at those levels probably does not deserve to survive. It is the prospect of a one-time billion-dollar loss that merits the adoption of a ceiling.”

Leave a comment

Filed under All The News That's Fit To Blog

Around The Web

A few items from around the web:

(1) The Financial Times has an article on the U.S. Supreme Court’s new-found interest in business cases. Although the authors note that many of these cases result in narrow decisions, they cite the Dura decision on loss causation as having had a “big impact.”

(2) The Wall Street Journal Law Blog has a follow-up post on the lead plaintiff dispute in the Merck securities litigation. The lead plaintiffs have asked the court to permit Bernstein Litowitz to act as co-lead counsel.

(3) An op-ed in the Financial Times from earlier this month discusses the negative effects abroad of U.S. shareholder litigation. The author, who works for the British Association of Insurers, advocates the curbing of lawsuits and an increase in shareholder rights. Thanks to Werner Kranenburg for the link.

Leave a comment

Filed under All The News That's Fit To Blog

CMS Energy Settles

CMS Energy, a Michigan-based energy provider, has announced the preliminary settlement of the securities class action pending against the company in the E.D. of Michigan. The case, which was originally filed in May 2002, alleges that CMS Energy made various false and misleading statements by including the results of certain “round-trip” energy trades entered into by one of its Texas-based subsidiaries as part of its revenues and expenses. The proposed settlement is for $200 million, of which CMS Energy will pay $123.5 million and its insurers will pay $76.5 million.

Leave a comment

Filed under Settlement

Supreme Court To Address Scienter

After eleven years, the PSLRA’s scienter pleading standard finally will be addressed by the U.S. Supreme Court. On Friday, the court granted certiorari in Tellabs, Inc. v. Makor Issues & Rights, Ltd. on appeal from the U.S. Court of Appeals for the Seventh Circuit.

The question presented on appeal is whether, and to what extent, a court must consider or weigh competing inferences in determining whether a complaint has alleged sufficient facts to establish a strong inference of scienter. The Seventh Circuit held that the plaintiff was entitled to more than the most plausible of competing inferences. Instead, a court should “allow the complaint to survive if it alleges facts from which, if true, a reasonable person could infer that the defendant acted with the required intent.” In their cert petition (via SCOTUSblog), defendants argued that this is the most lenient of the “four meaningfully different interpretations of the strong inference standard” that have been adopted by federal circuit courts and urged the Supreme Court to resolve the circuit split.

Links to the various cert petition briefs can be found on SCOTUSblog, which also notes that the Supreme Court has ordered expedited briefing in the case and may be planning to hear it during the March 2007 session. Thanks to Greg Harris for the tip.

Leave a comment

Filed under Appellate Monitor

Special Section

Just before the holidays, in its Dec. 18 issue, the New York Law Journal ran its annual special section on securities litigation and regulation. It includes articles on: (1) a recent scheme liability decision in the Enron case; and (2) the use of agency and respondeat superior theories by plaintiffs to reach non-speaking defendants.

Leave a comment

Filed under All The News That's Fit To Blog

Adding Up The Numbers

The race to release annual data on securities class action filings has heated up to the point where the two major players both have decided not to wait for the final numbers to come in. This week saw the publication of “2006: A Year in Review” from Cornerstone Research/Stanford Law School Securities Class Action Clearinghouse and “Recent Trends in Shareholder Class Action Litigation: Filings Plummet, Settlements Soar” from NERA Economic Consulting. The reports use filing data through mid-December 2006.

The findings include:

(1) Filings plunged to a record low since the passage of the PSLRA in 1995. As usual, the reports differed in their calculation of the exact number of filings. Cornerstone found that there were 110 filings (as compared to a post-PSLRA average of 193), while NERA found there were 129 filings (as compared to a post-PSLRA average of 239).

(2) The average settlement, excluding settlements over $1 billion, was $34 million (up 37% over 2005). The increase is driven almost entirely by the growth in settlements over $100 million. (NERA)

(3) There has been a dramatic decrease in the total market capitalization losses associated with filings (44% decline in losses measured as of the last day of the class perod), which is a product of fewer filings and lower market capitalization losses per filing. (Cornerstone)

(4) A significant portion of cases are dismissed within the first two years. The Second and Ninth Circuits, which together receive the most cases, dismiss approximately 20% within this time period. The Fourth Circuit has the highest rate, dismissing 31% of cases within two years, while the Tenth Circuit has the lowest, at 5%. (NERA)

Why the decline in filings this past year? Possible reasons put forward by the reports include better corporate governance (Cornerstone and NERA), a strengthened federal enforcement environment (Cornerstone), a strong stock market combined with lower stock price volatility (Cornerstone), and distraction on the part of the plaintiffs’ bar (NERA).

Addition: Point of Law and D&O Diary present some thoughts on the filings decline.

Leave a comment

Filed under Lies, Damn Lies, And Statistics

Better To Opt Out?

Earlier this month, the New York Sun ran an interesting feature article on the Time Warner securities litigation. Although the securities class action settled for $2.5 billion last year, some institutional investors who decided to opt-out of the case appear to be doing even better than the class participants. The State of Alaska, for example, recently settled its related state court action against Time Warner for 83% of its estimated damages. Thanks to Point of Law for the link.

Quote of note: “While Alaska may be the most successful opt-out plaintiff thus far, others have also improved their lot by going it alone. A Dutch retirement fund, Stichting Pensioenfonds ABP, won a $20 million settlement from Time Warner earlier this year on what ABP said was $150 million in investment losses. ABP’s chief counsel told a Dutch newspaper, Het Financieele Dagblad, that the fund would have gotten only $1 million to $3 million if it had stayed in the class.”

Addition: Lies, Damn Lies, & Forward-Looking Statements has a post on this article that offers more details and links on the opt-out cases.

Leave a comment

Filed under All The News That's Fit To Blog

I’ll Bet You Won’t Print This

The fee-shifting imposed by the Enron court – related to claims brought against Alliance Capital – continues to make news. At the time of the decision, the Wall Street Journal (subscrip. req’d) published an editorial lauding the result. In today’s edition, the plaintiff’s attorney fights back with a letter that he challenges the paper to print (a bet he happily loses), while the newspaper’s editorial board defends its analysis. The WSJ Law Blog has the blow-by-blow (free content).

Leave a comment

Filed under Enron, Motion To Dismiss Monitor

Truth On The Market

If the market were aware during the class period of the allegedly omitted information, could the investors later argue that they were defrauded? Some courts have declined to consider a “truth on the market” defense raised as part of a motion to dismiss because it presents factual issues. Other courts, however, have been willing to examine public documents available to investors and conclude that any failure on the part of the defendants to disclose material information was excused by its availability from other sources. Two recent decisions have taken the latter approach and dismissed securities fraud claims.

In Ley v. Visteon Corp., 2006 WL 2559795 (E.D. Mich. Aug. 31, 2006), the court considered whether claims based on “Visteon’s Ford-related operational issues” should be dismissed because these issues were discussed in analyst reports and newspaper articles during the class period. Although the plaintiffs argued that a truth on the market defense would be premature at the motion to dismiss stage of the case, the court disagreed, finding that it could “consider publications by market analysts in determining if the market had sufficient knowledge of Defendants’ various deficiencies.” The court concluded that it was clear from these publications that the market was aware of “Visteon’s inability to shed unprofitable business lines inherited from Ford, high labor costs, price reductions owed to Ford, and general reliance upon Ford.”

Similarly, in In re Discovery Laboratories Sec. Litig., 2006 WL 3227767 (E.D. Pa. Nov. 1, 2006), the court examined whether certain statements related to the FDA-approval process for a drug product were materially misleading in light of the public information available to the market. The court held that the “‘truth on the market’ defense does not require that any investor should be capable of finding the information and understanding its significance based on a single click for a simple Web search.” Instead, the standard is “reasonable investors, those who we can assume exercise due investment diligence.” Based on public reports of facility problems and the widely known fact that the company would need to comply with FDA regulations to obtain approval for the drug, the court found that the alleged misstatements related to those issues were inactionable.

Leave a comment

Filed under Motion To Dismiss Monitor